Buzzing Stock: Teva Pharmaceutical Industries Limited (NYSE:TEVA)


As per the research groups listed in Thomson Reuters survey, Teva Pharmaceutical Industries Limited (NYSE:TEVA), the stock can touch mean price target of $71.050 in coming period. This price target highlights the recommendations of leading experts in the market. Thomson Reuters studies the brokerages research reports to reach this price target. The latest poll indicate that the company may record earnings of $1.400 per share in looming quarter and $5.300 during current fiscal. Technical Forecast While evaluating Teva Pharmaceutical Industries on the technical side, it is seen that the firm’s shares price is at $1.966, which is +3.758% off 50-day MA of $52.329. The stock is $-0.966, which is -1.749% off $55.261, which is 200-day MA of Teva Pharmaceutical Industries . MA here stands for moving average. Teva Pharmaceutical Industries Limited (NYSE:TEVA) stock made a high of $72.310 in last 12-months while the lowest level in same period was $48.010. It entails if stock price makes a movement of over $-18.015, it will make a new 52-week high. In the case of $+13.091% points decline, it will touch a new 52-week low. Valuation Level The valuation of Teva Pharmaceutical Industries is done by analysts by using price-to-earnings ratio. This ratio considers the latest price and profits for valuating a stock. The ratio is calculated by dividing stock price by annual EPS. For now, Teva Pharmaceutical Industries Limited (NYSE:TEVA) P/E ratio is 28.147. The stakeholders can further gauge a firm’s performance by calculating Price-to-Earnings-Growth ratio, and for Teva Pharmaceutical Industries it stands at 1.960.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 29 times, 1 visits today)